Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gui Zhao

Showing results (141-150 of 142) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 142 results.
Frontiers in Immunology|July 10, 2024
Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38Song Li, Dianze Chen, Yanan Yang, et al.
Frontiers in Medicine|April 18, 2022
A Matrix Prediction Model for the 6-Month Mortality Risk in Patients With Anti-Melanoma Differentiation-Associated Protein-5-Positive DermatomyositisZhi-Ming Ouyang, Jian-Zi Lin, Ao-Juan Tang, et al.
Pageof 15

Showing results (141-150 of 142) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 142 results.
Frontiers in Immunology|July 10, 2024
Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38Song Li, Dianze Chen, Yanan Yang, et al.
Frontiers in Medicine|April 18, 2022
A Matrix Prediction Model for the 6-Month Mortality Risk in Patients With Anti-Melanoma Differentiation-Associated Protein-5-Positive DermatomyositisZhi-Ming Ouyang, Jian-Zi Lin, Ao-Juan Tang, et al.
Pageof 15